IQV * Stock Overview
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
IQVIA Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3,966.00 |
| 52 Week High | US$4,944.96 |
| 52 Week Low | US$3,778.00 |
| Beta | 1.51 |
| 1 Month Change | -4.61% |
| 3 Month Change | -2.33% |
| 1 Year Change | -8.05% |
| 3 Year Change | -12.46% |
| 5 Year Change | 75.06% |
| Change since IPO | 74.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| IQV * | MX Life Sciences | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -8.1% | 0% | 0% |
Return vs Industry: IQV * exceeded the MX Life Sciences industry which returned -12.6% over the past year.
Return vs Market: IQV * exceeded the MX Market which returned -9.7% over the past year.
Price Volatility
| IQV * volatility | |
|---|---|
| IQV * Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: IQV *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine IQV *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 88,000 | Ari Bousbib | www.iqvia.com |
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
IQVIA Holdings Inc. Fundamentals Summary
| IQV * fundamental statistics | |
|---|---|
| Market cap | Mex$650.59b |
| Earnings (TTM) | Mex$27.36b |
| Revenue (TTM) | Mex$306.95b |
23.8x
P/E Ratio2.1x
P/S RatioIs IQV * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IQV * income statement (TTM) | |
|---|---|
| Revenue | US$15.41b |
| Cost of Revenue | US$10.03b |
| Gross Profit | US$5.38b |
| Other Expenses | US$4.00b |
| Earnings | US$1.37b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.79 |
| Gross Margin | 34.89% |
| Net Profit Margin | 8.91% |
| Debt/Equity Ratio | 230.6% |
How did IQV * perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/16 19:08 |
| End of Day Share Price | 2025/02/24 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
IQVIA Holdings Inc. is covered by 40 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Gregory Bolan | Avondale Partners |
| Eric Coldwell | Baird |